Stock is now moving with a positive distance from the 200 day simple moving average of approximately 39.89%, and has a solid year to date (YTD) performance of 522.86% which means the stock is constantly adding to its value from the previous fiscal year end price. The stock has relative volume of 19.29.
Market Capitalization can be thought of as the overall price to buy the company.
ATR value of company was 0.46.
Health care stocks have given back most of their prior gains, with the NYSE Health Care Index declining 0.2% this afternoon while shares of health care companies in the S&P 500 were down about 0.4% as a group. Their 52-Week High and Low are noted here. Beta factor, which measures the riskiness of the security, was observed as 2.70. SSH's value Change from Open was at -28.05% with a Gap of 35.87%.
EPS growth in past 5 year was 23.00%.
EPS growth estimate for this year is set at 45.10%. The stock is presently trading down its SMA-50 of $49.91. Over the last week of the month, it was -34.14%, 379.12% over the last quarter, and 198.63% for the past six months. The company has dropped -17.90% in past 3 months and in the last five trades has moved down -1.68%.
Looking about the past performance history, the company plunged -37.18% in past week and declined -54.58% in one month.
Along with these its year to date performance is standing at 522.86%.
Sunshine Heart, Inc.is a medical device company engaged in the commercialization of the C-Pulse Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure. Additionally, SSH had a day price range of $2.06 to $2.35. Analysts have a mean recommendation of 2.00 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). (SSH)'s latest closing price was 39.89% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at -52.48% and -41.26% compared with the 20 Day Moving Average.